Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma
Our results are consistent with the hypothesis that an individual's risk of developing a peripheral neuropathy after thalidomide treatment can be mediated by polymorphisms in genes governing repair mechanisms and inflammation in the peripheral nervous system. These findings will contribute to the development of future neuroprotective strategies with thalidomide therapy and the better use of this important compound.
797-804
Johnson, David C.
95bd8f42-2b59-4788-86dd-a32087bf554b
Corthals, Sophie L.
f09a87aa-076d-4b12-a1d3-e9161b7f4de5
Walker, Brian A.
7e45e107-ca85-4368-8673-7177f2328405
Ross, Fiona M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Gregory, Walter M.
4a7a4c5a-0a88-4ba2-8f08-0c035dd0b6db
Dickens, Nicholas J.
a22b3b23-76ab-493a-b34e-669a2c3ee1c4
Lokhorst, Henk M.
b34bd3e6-c182-4202-9d9b-3dba4024b3ae
Goldschmidt, Hartmut
f0cecca6-05ba-4462-8fa5-5bb85d0db5ad
Davies, Faith E.
9ea9e143-ac51-431b-8cb5-57b8dc0a38af
Durie, Brian G. M.
c8112764-4ce3-4e82-ba22-63b544edd56e
Van Ness, Brian
bda6aafd-5f13-415b-9953-33b4437a2f80
Child, J. Anthony
1a7a739b-5295-4818-a455-3c67d9020abc
Sonneveld, Pieter
80d2c1ed-b2f8-4e26-aaaa-6ba42fff0744
Morgan, Gareth J.
d285dcf8-ac2c-4fe0-acf9-4787eb025939
1 March 2011
Johnson, David C.
95bd8f42-2b59-4788-86dd-a32087bf554b
Corthals, Sophie L.
f09a87aa-076d-4b12-a1d3-e9161b7f4de5
Walker, Brian A.
7e45e107-ca85-4368-8673-7177f2328405
Ross, Fiona M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Gregory, Walter M.
4a7a4c5a-0a88-4ba2-8f08-0c035dd0b6db
Dickens, Nicholas J.
a22b3b23-76ab-493a-b34e-669a2c3ee1c4
Lokhorst, Henk M.
b34bd3e6-c182-4202-9d9b-3dba4024b3ae
Goldschmidt, Hartmut
f0cecca6-05ba-4462-8fa5-5bb85d0db5ad
Davies, Faith E.
9ea9e143-ac51-431b-8cb5-57b8dc0a38af
Durie, Brian G. M.
c8112764-4ce3-4e82-ba22-63b544edd56e
Van Ness, Brian
bda6aafd-5f13-415b-9953-33b4437a2f80
Child, J. Anthony
1a7a739b-5295-4818-a455-3c67d9020abc
Sonneveld, Pieter
80d2c1ed-b2f8-4e26-aaaa-6ba42fff0744
Morgan, Gareth J.
d285dcf8-ac2c-4fe0-acf9-4787eb025939
Johnson, David C., Corthals, Sophie L., Walker, Brian A., Ross, Fiona M., Gregory, Walter M., Dickens, Nicholas J., Lokhorst, Henk M., Goldschmidt, Hartmut, Davies, Faith E., Durie, Brian G. M., Van Ness, Brian, Child, J. Anthony, Sonneveld, Pieter and Morgan, Gareth J.
(2011)
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.
Journal of Clinical Oncology, 29 (7), .
(doi:10.1200/JCO.2010.28.0792).
(PMID:21245424)
Abstract
Our results are consistent with the hypothesis that an individual's risk of developing a peripheral neuropathy after thalidomide treatment can be mediated by polymorphisms in genes governing repair mechanisms and inflammation in the peripheral nervous system. These findings will contribute to the development of future neuroprotective strategies with thalidomide therapy and the better use of this important compound.
This record has no associated files available for download.
More information
e-pub ahead of print date: 18 January 2011
Published date: 1 March 2011
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 337735
URI: http://eprints.soton.ac.uk/id/eprint/337735
ISSN: 1527-7755
PURE UUID: a2abcbce-8271-4131-a4d2-8ac25c6b1c0a
Catalogue record
Date deposited: 02 May 2012 14:03
Last modified: 14 Mar 2024 10:57
Export record
Altmetrics
Contributors
Author:
David C. Johnson
Author:
Sophie L. Corthals
Author:
Brian A. Walker
Author:
Fiona M. Ross
Author:
Walter M. Gregory
Author:
Nicholas J. Dickens
Author:
Henk M. Lokhorst
Author:
Hartmut Goldschmidt
Author:
Faith E. Davies
Author:
Brian G. M. Durie
Author:
Brian Van Ness
Author:
J. Anthony Child
Author:
Pieter Sonneveld
Author:
Gareth J. Morgan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics